Figure 1.
Patient selection for inclusion into study.
Patients included had FIGO grade 1 EEC, no myometrial invasion, and no lymphovascular space invasion. Synchronous ovarian malignancy was an exclusion criterion. Pelvic/peritoneal fluid cytology positive for carcinoma was not an exclusion criterion. EEC, endometrioid endometrial adenocarcinoma; MI, myometrial invasion; LVSI, lymphovascular space invasion.